• Clinical and Experimental Pediatrics
• /
• 제57권9호
• /
• pp.379-383
• /
• 2014

Recombinant growth hormone (GH) is an effective treatment for short children who are born small for gestational age (SGA). Short children born SGA who fail to demonstrate catch-up growth by 2-4 years of age are candidates for GH treatment initiated to achieve catch-up growth to a normal height in early childhood, maintain a normal height gain throughout childhood, and achieve an adult height within the normal target range. GH treatment at a dose of $35-70{\mu}g/kg/day$ should be considered for those with very marked growth retardation, as these patients require rapid catch-up growth. Factors associated with response to GH treatment during the initial 2-3 years of therapy include age and height standard deviation scores at the start of therapy, midparental height, and GH dose. Adverse events due to GH treatment are no more common in the SGA population than in other conditions treated with GH. Early surveillance in growth clinics is strongly recommended for children born SGA who have not caught up. Although high dose of up to 0.067 mg/kg/day are relatively safe for short children with growth failure, clinicians need to remain aware of long-term mortality and morbidity after GH treatment.

• Clinical and Experimental Pediatrics
• /
• 제53권9호
• /
• pp.845-851
• /
• 2010

Purpose: Recombinant human growth hormone (rhGH) has been widely used to treat short stature. However, there are some concerns that growth hormone treatment may induce skeletal maturation and early onset of puberty. In this study, we investigated whether rhGH can directly affect the neuronal activities of of gonadotropin-releasing hormone (GnRH). Methods: We performed brain slice gramicidin-perforated current clamp recording to examine the direct membrane effects of rhGH on GnRH neurons, and a whole-cell voltage-clamp recording to examine the effects of rhGH on spontaneous postsynaptic events and holding currents in immature (postnatal days 13-21) and adult (postnatal days 42-73) mice. Results: In immature mice, all 5 GnRH neurons recorded in gramicidin-perforated current clamp mode showed no membrane potential changes on application of rhGH (0.4, $1{\mu}g/mL$). In adult GnRH neurons, 7 (78%) of 9 neurons tested showed no response to rhGH ($0.2-1{\mu}g/mL$) and 2 neurons showed slight depolarization. In 9 (90%) of 10 immature neurons tested, rhGH did not induce any membrane holding current changes or spontaneous postsynaptic currents (sPSCs). There was no change in sPSCs and holding current in 4 of 5 adult GnRH neurons. Conclusion: These findings demonstrate that rhGH does not directly affect the GnRH neuronal activities in our experimental model.

• 생명과학회지
• /
• 제31권3호
• /
• pp.356-365
• /
• 2021

최근, 본 연구진은 담수 환경 유래 한천 분해 세균인 Cellvibrio sp KY-GH-1 (KCTC13629BP)의 전체 유전체 염기 서열을 분석하여 아가로오스를 L-AHG 및 D-갈락토오스로 가수분해시키는 아가레이즈들을 암호화하는 유전 정보를 탐색하였다. 그 결과, KY-GH-1 균주는 유전체 상의 약 77 kb 길이의 아가레이즈 유전자 클러스터 내에 9개의 β-아가레이즈 유전자들과 2개의 α-네오아가로비오스 가수분해효소(α-NABH) 유전자들을 지닌 것으로 나타났다. 이러한 유전자 정보를 바탕으로 KY-GH-1 균주가 한천을 탄소원으로 자화하기 위해 단량체인 L-AHG와 D-갈락토오스로 분해시키는 공정은, 엔도형 GH16 β-아가레이즈, 엔도형 GH86 β-아가레이즈 등에 의해 개시되어 NA4, NA6, NA8 등을 생성시킨 후, 이들에 대해 엑소형 GH50 β-아가레이즈가 추가로 작용하여 NA2를 생성시키고, 이어서 GH117 α-NABH가 작용하여 생성된 NA2를 단량체 L-AHG와 D-갈락토오스로 분해함으로써 종결되는 것으로 예측되었다. 대장균 발현 시스템과 PET-30a 벡터를 함께 사용하여, KY-GH-1 균주 유래의 GH50 패밀리 β-아가레이즈 유전자들(GH50A, GH50B, GH50C)과 GH117 패밀리 α-NABH 유전자들(GH117A α-NABH, GH117B α- NABH)을 발현시켜 His-태그 재조합 효소단백질들로 확보하여, 이들 효소단백질을 이용하여 효소 활성을 비교 분석한 결과, 재조합 GH50A β-아가레이즈가 세 개의 GH50A 패밀리 β-아가레이즈 동위효소들 중에서 가장 높은 엑소형 β-아가레이즈 활성을 나타내며, 또한 재조합 GH117A α-NABH가 NA2를 L-AHG와 D-갈락토오스로 강력하게 가수분해할 수 있으나 재조합 GH117B α-NABH는 NA2 가수분해 활성이 없음을 확인하였다. 연이어 GH50A β-아가레이즈 및 GH117A α-NABH의 효소 특성을 추가로 조사하였다. 아울러 이들 각 효소가 나타내는, 아가로오스를 분해하여 NA2를 생성시키는 효율성과 NA2를 분해하여 L-AHG 및 D-갈락토오스를 생성시키는 효율성을 평가하였다. 본 총설에서는, L-AHG 및 D-갈락토오스의 양산을 위한 아가로오스의 효소적 가수분해에 성공적으로 활용될 수 있을 것으로 기대되는, 담수 유래 한천 분해 세균 Cellvibrio sp. KY-GH-1 유래의 재조합 GH50A β-아가레이즈 및 GH117A α-NABH의 장점들에 대해 기술한다.

• Animal Bioscience
• /
• 제34권5호
• /
• pp.867-879
• /
• 2021

Objective: Fibronectin 3 (FN3) and immunoglobulin like modules (Ig) are usually collocated beside modular cellulase catalytic domains. However, very few researches have investigated the role of these modules. In a previous study, we have sequenced and analyzed bacterial metagenomic DNA in Vietnamese goats' rumen and found that cellulase-producing bacteria and cellulase families were dominant. In this study, the properties of modular cellulases and the role of a FN3 in unique endoglucanase belonging to glycosyl hydorlase (GH) family 5 were determined. Methods: Based on Pfam analysis, the cellulases sequences containing FN3, Ig modules were extracted from 297 complete open reading frames (ORFs). The alkaline, thermostability, tertiary structure of deduced enzymes were predicted by AcalPred, TBI software, Phyre2 and Swiss models. Then, whole and truncated forms of a selected gene were expressed in Escherichia coli and purified by His-tag affinity column for assessment of FN3 ability to enhance enzyme activity, solubility and conformation. Results: From 297 complete ORFs coding for cellulases, 148 sequences containing FN3, Ig were identified. Mostly FN3 appeared in 90.9% beta-glucosidases belonging to glycosyl hydrolase family 3 (GH3) and situated downstream of catalytic domains. The Ig was found upstream of 100% endoglucanase GH9. Rarely FN3 was seen to be situated downstream of X domain and upstream of catalytic domain endoglucanase GH5. Whole enzyme (called XFN3GH5 based on modular structure) and truncate forms FN3, XFN3, FN3GH5, GH5 were cloned in pET22b (+) and pET22SUMO to be expressed in single and fusion forms with a small ubiquitin-related modifier partner (S). The FN3, SFN3 increased GH5 solubility in FN3GH5, SFN3GH5. The SFN3 partly served for GH5 conformation in SFN3GH5, increased modules interaction and enzyme-soluble substrate affinity to enhance SXFN3GH5, SFN3GH5 activities in mixtures. Both SFN3 and SXFN3 did not anchor enzyme on filter paper but exfoliate and separate cellulose chains on filter paper for enzyme hydrolysis. Conclusion: Based on these findings, the presence of FN3 module in certain cellulases was confirmed and it assisted for enzyme conformation and activity in both soluble and insoluble substrate.

• Journal of Microbiology
• /
• 제44권1호
• /
• pp.64-71
• /
• 2006

To investigate the effects of the nucleotide sequences in Shine-Dalgarno (SD) and the spacer region (SD-ATG) on bovine growth hormone (bGH) gene expression, the expression vectors under the control of the T7 promoter (pT7-7 vector) were constructed using bGH derivatives (bGH1 & bGH14) which have different 5'-coding regions and were induced in E. coli BL21 (DE3). Oligonucleotides containing random SD sequences and a spacer region were chemically synthesized and the distance between the SD region and the initiation codon were fixed to nine bases in length. The oligonucleotides were annealed and fused to the bGH1 and bGH14 cDNA, respectively. When the bGH gene was induced with IPTG in E. coli BL21(DE3), some clones containing only bGH14 cDNA produced considerable levels of bGH in the range of $6.9\%\;to\;8.5\%$ of total cell proteins by SDS-PAGE and Western blot. Otherwise, the bGH was not detected in any clones with bGH1 cDNA. Accordingly, the nucleotide sequences of SD and the spacer region affect on bGH expression indicates that the sequences sufficiently destabilize the mRNA secondary structure of the bGH14 gene. When the free energy was calculated from the transcription initiation site to the +51 nucleotide of bGH cDNA using a program of nucleic acid folding and hybridization prediction, the constructs with values below -26.3 kcal/mole (toward minus direction) were not expressed. The constructs with the original sequence of bGH cDNA also did not show any expression, regardless of the free energy values. Thus, the disruption of the mRNA secondary structure may be a major factor regulating bGH expression in the translation initiation process. Accordingly, the first stem-loop among two secondary structures present in the 5'-end region of the bGH gene should be disrupted for the effective expression of bGH.

• 한국유기농업학회지
• /
• 제27권1호
• /
• pp.65-76
• /
• 2019

작물생육촉진과 병 방제 기능을 지닌 Bacillus velezensis GH1-13 균주의 대량배양을 위한 최적배지(glucose 0.5%, soy bean flour 0.8%, NaCl 0.15%, $K_2HPO_4$ 0.25%, $Na_2CO_3$ 0.05%, $MgSO_4.7H_2$ 0.1%) 조성을 확립하였다. 최적배지(MMS)를 이용하여 500 L 대용량 발효기에서 배양한 결과 총 균체수 $7.5{\times}10^9cells/mL$, $6.8{\times}10^9\;endospore\;cells/mL$ 및 90% 내생포자 형성률 등 안정된 대량생산을 확인하였다. 최적배지에서 배양한 GH1-13 균체와 배양 상층액의 경우 Colletotrichum gloeosporioides를 포함한 4종의 식물병원성 곰팡이에 대한 항진균활성을 보였다. 또한 식물생육촉진 호르몬의 일종인 IAA 생산량을 비교한 결과, 최적배지에서 배양한 경우 상업용 배지(TSB, R2A)에 비해 2.5~13배 이상 높은 생산성을 보였다. 더불어, 최적배지에 0.3% tryptophan을 첨가하여 배양했을 경우 28.50 mg/L의 IAA 최대 생산량을 보였으며, 이는 tryptophan을 첨가하지 않고 배양한 경우보다 약 4배 높은 수준이었다. 이러한 결과로 볼 때 본 연구에 사용된 B. velezensis GH1-13 균주는 작물생육촉진 및 곰팡이 병 방제 측면의 복합기능 생물학적 제제로서 매우 유용할 것으로 판단된다.

• Clinical and Experimental Pediatrics
• /
• 제52권8호
• /
• pp.922-929
• /
• 2009

목 적 : 성장 장애는 영아 및 소아에서 성장 속도가 같은 성별, 연령 보다 현저히 작은 경우를 지칭하며 여러 가지 원인에 의해서 발생할 수 있다. 저신장을 주소로 내원한 환자 중 성장 장애를 보이지만 성장호르몬 자극검사가 정상인 환자들의 임상적 특성 및 성장호르몬 치료에 대한 반응을 알아보고자 하였다. 방 법 : 1990년 1월부터 2008년 6월까지 서울대학교 어린이병원 소아청소년과에 내원한 어린이 중에서 성장속도가 연간 4 cm 미만이면서, 2가지 서로 다른 약제로 성장호르몬 자극검사를 시행하였을 때 정상 소견을 보이는 환자를 대상으로 하였다. SGA군과 AGA군으로 나누어 임상적인 특성을 비교하였으며, 성장호르몬 투여군에 대한 분석을 시행하였다. 결 과 : 총 39명의 환자가 연구에 포함되었으며, 남자가 25명(64%), 여자 14명(36%)이었고, SGA군 11명(28%), AGA군 28명(72%), 성장호르몬 투여군 16명(41%), 비 투여군 23명(59%)이었다. SGA군과 AGA군 모두에서 골연령이 역연령에 비하여 지연되어 있었으나(P=0.028), 두 군간의 차이는 없었다. 모든 환자에서 성장호르몬 자극검사 후 성장호르몬의 최고 농도는 10 ng/mL 이상이었고, clonidine을 사용하였을 때 성장호르몬의 최고농도가 30.4 (6.2, 92.0) ng/mL로 다른 약제에 비하여 유의하게 높았다(P=0.03). 성장호르몬 치료받은 환자 16명의 1년간 성장 속도는 7.7 (4.9, 11.1) cm/yr, 치료 받지 않고 추적관찰 된 6명은 3.7 (2.7, 4.5) cm/yr으로 유의한 차이가 있었다(P<0.001). 또한 성장호르몬 투여군에서 치료 1년 동안 신장 SDS는 0.3 (-0.1, 0.9) 증가하였고(P<0.001), 성장 속도의 변화는 4.8 (2.1, 7.7) cm/yr로 의미있게 증가하였다(P<0.001). 성장호르몬으로 치료받은 환자 중, 치료 후 1년간 성장속도는 SGA군에서 7.1 (5.1, 8.5) cm/yr, AGA군에서 8.2 (4.9, 11.1) cm/yr로 두 군 모두에서 성장호르몬 사용 전 1년 간의 성장 속도보다는 유의하게 증가하였다. 성장호르몬 치료를 시작할 때의 신장의 SDS가 -3 이상인 군과 -3 미만인 군으로 나누어 분석해 보았을 때, 성장호르몬 자극검사시의 IGF-I 농도가 SDS가 -3 미만인 군에서 유의하게 낮게 측정되었다(P=0.023). 결 론 : 성장 속도가 연간 4 cm 미만으로 감소하였으나 성장호르몬 자극검사가 정상인 환자들이 단기간의 성장호르몬 투여로 성장 속도의 증가가 있었으나 이들에서의 장기적인 성장호르몬 효과에 대하여는 향후 더 추적관찰이 필요하다. 또한 이들에서 부분적 인 성장호르몬 저항성 증후군의 가능성이 있으므로, 추후 이러한 환자들을 대상으로 IGF-I 생성 검사를 포함한, GH-IGF-I 축에 대한 검사를 시행하여 성장 장애의 원인을 밝혀야 할 것이다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제21권7호
• /
• pp.1033-1037
• /
• 2008

The purpose of the present study was to investigate the effects of chromium picolinate (CrPic) on growth hormone (GH) secretion and pituitary GH mRNA expression in finishing pigs. Forty eight crossbred pigs with an initial body weight of 65.57 kg (SD = 1.05) were blocked by body weight and randomly assigned to two treatments with three replicates. Each group was fed the diet supplemented with or without $200{\mu}g/kg$ chromium from CrPic for 40 days. The results showed that average daily gain of pigs was increased by 9.84% (p<0.05), and longissimus muscle area was increased by 17.29% (p<0.05) with the supplementation of CrPic. The results of GH dynamic secretion showed that supplemental CrPic increased the mean level and peak value of GH by 36.58% (p<0.05) and 26.60% (p<0.05), respectively, while there was no significant effect on basal value, peak amplitude and peak duration. Pituitary mRNA expression of GH was not significantly influenced by supplemental CrPic. These results indicated that CrPic increased pigs GH secretion without change of pituitary GH mRNA expression.

• 한국해양바이오학회지
• /
• 제8권1호
• /
• pp.1-9
• /
• 2016

The hydrolysis of biomass to fermentable sugar (saccharification) and to oligosaccharide is an essential process in biotechnology including biorefinery and biofood. Various macroalgae are commercially cultivated in several Asian countries as a useful resource for food and agar production. Agar is a major component of the cell walls of red algae that can be hydrolyzed by agarase. Agarases are classified into ${\alpha}$-agarase (E.C. 3.2.1.158) and ${\beta}$-agarase (E.C. 3.2.1.81) according to the cleavage pattern and grouped in the glycoside hydrolase (GH) family (GH-16, GH-58, GH-86, GH-96, and GH-118) based on the amino acid sequences of the proteins. Agarases have been isolated from various bacteria found in seawater and marine sediments. To increase productivity of the enzyme, a research on recombinant enzymes has been done. The application of recombinant agarase can be possible in the various filed such as energy, food, cosmetics, medical and so on. This paper reviews the source, biochemical characteristics and production system of recombinant agarases for further study.

• BMB Reports
• /
• 제28권5호
• /
• pp.437-442
• /
• 1995

The potency of yeast-derived methionyl-free human growth hormone (rhGH), which was obtained by removal of the N-terminal Met from methionyl-hGH, was estimated by in vitro and in vivo assays. In radio-receptor assay where the binding affinity of growth hormone to the receptor was estimated, the recombinant hGH showed 2.9 international units (IU) per mg of specific activity. In contrast, pitUitary-derived human growth hormone had a slightly lower receptor binding activity (2.5 IU/mg) compared with recombinant growth hormone. For the in vivo assay, efficacy of rhGH was tested by use of hypophysectomized rats, in which pituitary organs were surgically removed, resulting in the termination of growth hormone secretion. The weight-increase in rats by the injection of rhGH was almost identical to the result obtained by the injection of the same amount of pituitary-derived (international standard) hGH. A comparision of the secondary structures of rhGH and rMet-hGH by circular dichroism spectrophotometer demonstrated that the removal of the methionyl residue from rMet-hGH did not exert any effect on the structure of the growth hormone. In conclusion, methionyl-free human growth hormone produced from yeast was highly potent in biological activity and maintained a legitimate three dimensional structure.